Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 29300-269

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 29300-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 01

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 02

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 03

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 04

The text appears to be a label for a medication called "Rizatriptan Benzoate Orally Disintegrating Tablets USP" with two available doses, 5mg and 10mg. The rest of the text displays a graph with percentages on Y-axis and hours on X-axis, but the purpose of the graph is not clear.*

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 05

This appears to be a graph displaying the estimated probability of remedication or rescue with different doses of orally disintegrating tablets, specifically Rizatrptan Benzoste. The graph displays the percentage probability from 0-100% on the Y-axis and the hours post-dose on the X-axis. The data appears to show higher percentages of remedication or rescue with the 10mg dosage compared to the 5mg dosage or placebo.*

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 06

This is a graph that illustrates the percentage of rizatriptan benzoate orally disintegrating tablets compared to a placebo, obtained at 10, 15, and 20 hours after the Stage 2 dose. The label on the y-axis shows "Percent (35% C1)" and the x-axis shows "Hours Post Stage 2 Dose".*

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 07

This text provides the name of the company as "UNICHEM PHARMACEUTICALS (USA). INC." No further information is available.*

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 08

This is a company called Unichem Pharmaceuticals (USA) Inc.*

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 09

FDA Label Image

269f0768 2e6c 4188 Ba86 2d7420d31a21 10

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.